Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.35 |
| ▸ | DPP4 | P27487 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14519666 | 0.75 | CHRM1 (0.52) | CYP1A2CHRM1CHRM2CHRM4CHRM5 | |
| SCHEMBL11678374 | 0.70 | CHRM1 (0.38) | CHRM1CHRM2CHRM4CHRM5CHRM3 | |
| Water SCHEMBL731137 | 0.69 | — | — | |
| SCHEMBL1802826 | 0.69 | — | — | |
| SCHEMBL9220227 | 0.69 | — | — | |
| SCHEMBL15395568 | 0.68 | CYP1A2 (0.46) | CYP1A2CHRM1CHRM2CHRM4CHRM5 | |
| SCHEMBL153343 | 0.67 | — | — | |
| SCHEMBL8832247 | 0.67 | CYP1A2 (0.36) | CYP1A2 | |
| SCHEMBL5154233 | 0.67 | — | — | |
| SCHEMBL16255362 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0290583-B1 | $g(a) OLIGONUCLEOTIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1993-04-07 | — | — | EP | disclosed |
| EP-0290583-A1 | -g(a) OLIGONUCLEOTIDES. | CENTRE NAT RECH SCIENT (FR) | 1988-11-17 | — | — | EP | disclosed |
| WO-1988004301-A1 | alpha OLIGONUCLEOTIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS (FR) | 1988-06-16 | — | — | WO | disclosed |